Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
---|
Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
---|
Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
---|
Eton Pharmaceuticals (NASDAQ:ETON) reported its Q3 earnings results on Thursday, November 9, 2023 at 04:01 PM.
Here's what investors need to know about the announcement.
Eton Pharmaceuticals beat estimated earnings by 80.0%, reporting an EPS of $-0.02 versus an estimate of $-0.1.
Revenue was up $3.81 million from the same period last year.
Last quarter the company beat on EPS by $0.27 which was followed by a 38.08% increase in the share price the next day.
Here's a look at Eton Pharmaceuticals's past performance:
Quarter | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
---|---|---|---|---|
EPS Estimate | -0.09 | -0.14 | 0.01 | -0.15 |
EPS Actual | 0.18 | -0.10 | 0.04 | -0.12 |
Revenue Estimate | 6.51M | 4.56M | 9.12M | 3.05M |
Revenue Actual | 12.00M | 5.30M | 8.50M | 3.22M |
To track all earnings releases for Eton Pharmaceuticals visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: ETON